London Life Sciences Gets Boost

London’s life sciences industry received a boost as a US company invested £750,000 into a healthcare accelerator fund, reports the Evening Standard.

The US investment firm, Sandbox Industries, launched Healthbox, to give 10 entrepreneurs £75,000 and links to healthcare professionals, investors, retailers, office space and links to the NHS. The enterprise is backed by Bupa and Serco, which runs blood testing laboratories, with mentors coming from across the healthcare professions.

Looking for a job in the healthcare industry? Start by clicking here, now

Posted in Industry News, NewsTagged in , , , , , , , , ,

Norwich Research Park to Create 5,000 Jobs

Business Secretary Vince Cable has opened the Norwich Research Park, set to create 5,000 jobs, reports EDP24.com.

Mr Cable praised the park, calling it “world beating” and “ambitious” as he opened the facility equipped with office space and laboratories. The area the park has been built in is one with a high concentration of food and environmental science businesses, and the project is expected to create around 5,000 jobs over the next fifteen years.

Mr Cable reaffirmed the government’s commitment to the science industry by agreeing to a £26 million investment into the Norwich Research Park, as business plans have been submitted to the government. The park is expected to create the jobs by expanding thanks to the investment.

Looking for a job in the science industry? Start by clicking here, now

Posted in Industry News, Mobile News, NewsTagged in , , , , , , , , , , , , , , , , , , , , ,

Sanofi and Dendreon Battle for UK Market

Sanofi, a leading pharmaceutical company, has launched new cancer drug Jevtana in the UK, reports inpharm.com.

EMA approval was granted after extensive phase III trials which indicated the drug extended the life of men suffering from a type of prostate cancer considerably. It also slowed the time it took the cancer to progress compared to standard chemotherapy drugs.

However, Sanofi will face competition from US firm Dendreon, as they seek to launch their drug Provenge into the European market. Ultimately, Provenge extends the patient’s life further and reduces the risk of death by nearly 25%, though it would cost £25,000 more to treat a single patient than Jevtana, so would struggle to be able to convince NICE that it is worth the extra cost.

Looking for a job in science? Start by looking here, now

Posted in Industry News, Mobile News, NewsTagged in , , , , , , , , , , , , , , , , , , , , , , ,

Anti-Aging Drug Discovered

research team has discovered a new pharmaceutical on Easter Island which could be used to reverse the effects of aging, the Telegraph reports.

A chemical discovered in the soil of the island has been used to create Rapamycin which, when tested on children suffering from Hutchinson-Gilford Progeria Syndrome (HGPS), a disease which prematurely ages children, helped clear their cells of defects.

Researchers are already looking into the possibility of providing the drug to a wider market, after similarities between normal aging and HGPS were discovered. Dimitri Krainc, an author of the study into Rapamycin, believes a small dose of the drug can “extend the health and life span of our cells and organs”.

Looking for a job in science? Start by clicking here now

Posted in Industry News, Mobile News, NewsTagged in , , , , , , , , , , , , , , ,